{"Pulmonary": [0, 161], "arterial": [1, 39, 53, 338], "hypertension": [2, 54, 339], "is": [3, 25], "a": [4, 26, 42, 74, 349, 368], "progressive": [5], "disease": [6], "involving": [7], "proliferative": [8], "remodeling": [9], "of": [10, 87, 202, 257, 370], "the": [11, 17, 106, 114, 125, 160, 193, 197, 224, 239, 251, 258, 261, 267, 275, 304, 358], "pulmonary": [12, 38, 52, 133, 337], "vessels.": [13], "Despite": [14], "therapeutic": [15], "advances,": [16], "disease-associated": [18], "morbidity": [19], "and": [20, 32, 157, 164, 171, 210, 242, 263, 331], "mortality": [21], "remain": [22], "high.": [23], "Sotatercept": [24], "fusion": [27], "protein": [28], "that": [29, 314], "traps": [30], "activins": [31], "growth": [33], "differentiation": [34], "factors": [35], "involved": [36], "in": [37, 48, 73, 113, 124, 132, 137, 144, 159, 223, 238, 250, 266, 274, 348, 352], "hypertension.We": [40], "conducted": [41], "multicenter,": [43], "double-blind,": [44], "phase": [45], "3": [46, 99], "trial": [47], "which": [49, 189], "adults": [50], "with": [51, 297, 301, 318, 321, 336], "(World": [55], "Health": [56], "Organization": [57], "[WHO]": [58], "functional": [59, 146], "class": [60], "II": [61], "or": [62, 96, 151, 186], "III)": [63], "who": [64, 340], "were": [65, 70, 128, 177, 205, 294, 341], "receiving": [66, 342], "stable": [67, 343], "background": [68, 344], "therapy": [69], "randomly": [71], "assigned": [72, 206], "1:1": [75], "ratio": [76], "to": [77, 149, 184, 207, 212, 236, 248, 285], "receive": [78, 208, 213], "subcutaneous": [79], "sotatercept": [80, 209, 240, 262, 298, 319, 346], "(starting": [81], "dose,": [82, 91], "0.3": [83], "mg": [84, 93], "per": [85, 94], "kilogram": [86], "body": [88], "weight;": [89], "target": [90], "0.7": [92], "kilogram)": [95], "placebo": [97, 252, 264, 322], "every": [98], "weeks.": [100], "The": [101, 215, 254, 288], "primary": [102], "end": [103, 120, 292], "point": [104], "was": [105, 190, 228, 279, 310], "change": [107, 131, 136, 217, 268], "from": [108, 218, 269], "baseline": [109, 219, 270], "at": [110, 179, 220, 271], "week": [111, 180, 198, 221, 272], "24": [112, 181, 199, 222, 273], "6-minute": [115, 225, 276, 359], "walk": [116, 226, 277, 360], "distance.": [117], "Nine": [118], "secondary": [119, 291], "points,": [121], "tested": [122], "hierarchically": [123], "following": [126], "order,": [127], "multicomponent": [129], "improvement,": [130], "vascular": [134], "resistance,": [135], "N-terminal": [138], "pro-B-type": [139], "natriuretic": [140], "peptide": [141], "level,": [142], "improvement": [143, 351], "WHO": [145], "class,": [147], "time": [148, 183], "death": [150, 185], "clinical": [152, 187], "worsening,": [153, 188], "French": [154], "risk": [155], "score,": [156], "changes": [158], "Arterial": [162], "Hypertension-Symptoms": [163], "Impact": [165], "(PAH-SYMPACT)": [166], "Physical": [167], "Impacts,": [168], "Cardiopulmonary": [169], "Symptoms,": [170], "Cognitive/Emotional": [172, 306], "Impacts": [173, 307], "domain": [174, 308], "scores;": [175], "all": [176], "assessed": [178, 191, 356], "except": [182], "when": [192], "last": [194], "patient": [195], "completed": [196], "visit.A": [200], "total": [201], "163": [203], "patients": [204, 335], "160": [211], "placebo.": [214, 363], "median": [216], "distance": [227, 278], "34.4": [229], "m": [230, 244, 281], "(95%": [231, 245, 282], "confidence": [232], "interval": [233], "[CI],": [234], "33.0": [235], "35.5)": [237], "group": [241], "1.0": [243], "CI,": [246, 283], "-0.3": [247], "3.5)": [249], "group.": [253], "Hodges-Lehmann": [255], "estimate": [256], "difference": [259], "between": [260], "groups": [265], "40.8": [280], "27.5": [284], "54.1;": [286], "P<0.001).": [287], "first": [289], "eight": [290], "points": [293], "significantly": [295], "improved": [296], "as": [299], "compared": [300], "placebo,": [302], "whereas": [303], "PAH-SYMPACT": [305], "score": [309], "not.": [311], "Adverse": [312], "events": [313], "occurred": [315], "more": [316], "frequently": [317], "than": [320, 362], "included": [323], "epistaxis,": [324], "dizziness,": [325], "telangiectasia,": [326], "increased": [327, 332], "hemoglobin": [328], "levels,": [329], "thrombocytopenia,": [330], "blood": [333], "pressure.In": [334], "therapy,": [345], "resulted": [347], "greater": [350], "exercise": [353], "capacity": [354], "(as": [355], "by": [357, 365], "test)": [361], "(Funded": [364], "Acceleron": [366], "Pharma,": [367], "subsidiary": [369], "MSD;": [371], "STELLAR": [372], "ClinicalTrials.gov": [373], "number,": [374], "NCT04576988.).": [375]}